Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Yesterday, Feb. 19, 2014, 110 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $21.54 to $422,568,000.00. Highlighted Stocks Traded by Insiders: Dr Pepper Snapple Group (DPS) - FREE Research Report Stephens Angela A. who is Sr. Vice President, Controller at Dr Pepper Snapple Group sold 4,000 shares at $50.40 on Feb. 19, 2014. Following this transaction, the Sr. Vice President, Controller owned 4,795 shares meaning that the stake was reduced by 45.48% with the 4,000-share transaction. The shares most recently traded at $51.06, up $0.66, or 1.3% since the insider transaction. Historical insider transactions for Dr Pepper Snapple Group go as follows:
12-Week # shares sold: 3,457
24-Week # shares sold: 3,457
The average volume for Dr Pepper Snapple Group has been 1.4 million shares per day over the past 30 days. Dr Pepper Snapple Group has a market cap of $10.2 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 4.6% year-to-date as of the close of trading on Wednesday. The Company's brand portfolio includes Dr Pepper, 7UP, Snapple, Mott's, Hawaiian Punch, Canada Dry, A&W, Sunkist, Pe afiel, Squirt and Clamato and is the third largest soft drinks producer in the U.S. with 15.6% of the market. The stock currently has a dividend yield of 3.24%. The company has a P/E ratio of 16.6. Currently there are 2 analysts that rate Dr Pepper Snapple Group a buy, 1 analyst rates it a sell, and 8 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on DPS - FREETheStreet Quant Ratings rates Dr Pepper Snapple Group as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Dr Pepper Snapple Group Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.